According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

Diabetes is the most common cause of chronic kidney disease (CKD). Around 33 percent of adults with diabetes may also have CKD. When diabetes causes CKD, its sometimes called diabetic kidney disease.

Emerging research indeed suggests glucose monitors may offer benefits beyond insulin management, including improved glycemic ...

Researchers are exploring drugs like Ozempic, Mounjaro, and Wegovy to treat or prevent a range of conditions, including ...

The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.

As weight loss injectables become more widely available, many people wonder whether metformin is now outdated or whether ...

Treatment of type 2 diabetes is not limited to the occasional visit to the doctor: It includes important types of self-care in addition to regular medical care from doctors and other healthcare ...

GLP-1RA (glucagon-like peptide-1 receptor agonist) medications, which are prescribed to treat Type 2 diabetes and to help ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

For years, type 2 diabetes was considered a lifelong condition that could only be managed—not reversed. However, one landmark ...